Experiment 335154

Worktypes

MASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BYORD SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

RIBOSTAMYCIN,3-N-ACETYL:

Details

PropertyValue
Pharmacology
ANTIBACTERIAL ACTIVITY
OrganismStreptomyces ribosidificus (STREPTOMYCETACEAE)
CitationKOJIMA,M: EZAKI,N: AMANO,S: INOUYE,S: NIIDA,T:. (1975). BIOCONVERSION OF RIBOSTAMYCIN (SF-733). II. ISOLATION AND STRUCTURE OF 3-N-ACETYLRIBOSTAMYCIN, A MICROBIOLOGICALLY INACTIVE PRODUCT OF RIBOSTAMYCIN PRODUCED BY STREPTOMYCES RIBOSIDIFICUS.. 28()
Amount utilized
Compound isolated
Dose amount20.0 MG
Number3
Qualitative resultWEAK ACTIVITY
AnimalAGAR PLATE
Per unitML
Dose expressionCONC USED